Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 14, 2019

SELL
$5.98 - $13.98 $152,185 - $355,777
-25,449 Closed
0 $0
Q4 2018

Nov 08, 2023

SELL
$5.22 - $10.44 $114,840 - $229,680
-22,000 Reduced 46.37%
25,449 $156,000
Q4 2018

Feb 13, 2019

SELL
$5.22 - $10.44 $114,840 - $229,680
-22,000 Reduced 46.37%
25,449 $157,000
Q2 2018

Nov 08, 2023

SELL
$12.85 - $18.45 $128,500 - $184,500
-10,000 Reduced 17.41%
47,449 $642,000
Q2 2018

Aug 14, 2018

SELL
$12.85 - $18.45 $128,500 - $184,500
-10,000 Reduced 17.41%
47,449 $643,000
Q1 2018

Nov 08, 2023

BUY
$12.5 - $19.75 $718,112 - $1.13 Million
57,449 New
57,449 $1.02 Billion
Q1 2018

May 14, 2018

BUY
$12.5 - $19.75 $718,112 - $1.13 Million
57,449 New
57,449 $1.02 Million

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.